Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, announces today that it has acquired at the end ...

Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, announces today that it has acquired at the end ...

Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of ...

Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the ...

Axsome Therapeutics shows strong revenue growth with promising pipeline drugs for migraine, fibromyalgia, and narcolepsy.

Centessa Pharmaceuticals, founded from the merger of 10 biotech companies, is based on an asset-centric model, primarily ...

Pitolisant hydrochloride is under clinical development by Bioprojet SCR and currently in Phase II for Autism Spectrum Disorder (ASD).

Samelisant (SUVNG-3031) is under development for the treatment of narcolepsy with and without cataplexy and cognitive disorders. The drug candidate is administered orally in the form of tablet. The ...

Several brokerages have updated their recommendations and price targets on shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) in the last few weeks: 12/12/2024 – Jazz Pharmaceuticals had its “overweight” ...

People with narcolepsy may feel refreshed after waking but often become very sleepy during the day—this is called excessive daytime sleepiness (EDS). They may also experience interrupted sleep at ...

There are two types of narcolepsy, and both cause EDS. Most people with Type 1 (with cataplexy — the sudden loss of muscle tone explained above) have low levels of the brain hormone hypocretin ...